Indeed, previous work has shown that TGF‐β1 can polarize PCs toward anti‐inflammatory phenotypes in vitro,37 which may similarly occur in AD to attenuate the neuroinflammatory response in late‐stage disease. This evidence concerns the gene TGFB1 and Alzheimer disease.